About Jasco Labs
Jasco Labs was a Healthcare company based in Chandigarh (India) founded in 2005. It manufactures and trades antibiotics, anti-allergic, and psychiatric medicines globally. It operates on a B2B and Contract Manufacturing model. Its Indian entity Jasco Labs Private Limited reported revenue of ₹5.90 Cr. The company is recorded as dissolved. Jasco Labs offers products and services including Capsules, Tablets, Injections, Cream, and Syrup. Its focus areas include Pharmaceuticals, Medicines, Antibiotics and Anti-Allergic and Manufacturing Services. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Jasco Labs, established in 2005, is a manufacturer and trader of pharmaceutical products including antibiotics, calcium preparations, anti-allergic, and psychiatric medicines. They operate through advanced facilities in India and New Zealand, offering contract manufacturing and third-party services. The company focuses on high-quality production with WHO-GMP standards, supplying formulations like tablets and injections to various clients in the pharmaceutical industry. Their activities include trading and marketing support to ensure effective distribution.
- Headquarters Chandigarh, India
- SectorsHealthcare
- Email••••••••
- Website jascolabs.com
- Social Facebook
- Legal Name Jasco Labs Private Limited
- Date of Incorporation 07 Jul, 2005
- Jurisdiction Chandigarh, India
- Annual Revenue₹5.90 Cr
FY 2024 · +3% YoY
- Net Profit₹16.9 Lakh
FY 2024 · 3% margin
- EBITDA₹27.4 Lakh
FY 2024 · 5% margin
Associated legal entities of Jasco Labs
Jasco Labs operates through Jasco Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jasco Labs Private Limited CIN U24230CH2005PTC028640 | Active | 07 Jul 2005 | Chandigarh, Chandigarh | ₹5.9 Cr | – | 3 | View details |
Products & Services of Jasco Labs
Jasco Labs offers a comprehensive portfolio of products and services, including Capsules, Tablets, Injections, Cream, and Syrup.
Medicines in capsule form for various treatments.
Solid dosage forms for antibiotic and allergic treatments.
Injectable medicines for rapid therapeutic effects.
Topical applications for skin-related conditions.
Liquid formulations for easy consumption and dosing.
Board of directors of Jasco Labs Private Limited (Jasco Labs)
Jasco Labs Private Limited is the primary company behind Jasco Labs. The board of Jasco Labs Private Limited currently have 3 directors; the longest-serving is Ravdeep Singh Matta, appointed in 2005. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravdeep Singh Matta DIN 01589954 | Director | 07 Jul 2005 | 21 yrs 3 mo | Jasco Labs Private Limited |
| Jasmeet Singh DIN 01590005 | Director | 07 Jul 2005 | 21 yrs 3 mo | Jasco Labs Private Limited |
| Raminder Singh Matta DIN 01590053 | Director | 07 Jul 2005 | 21 yrs 3 mo | Jasco Labs Private Limited |
Financials of Jasco Labs
Figures of Jasco Labs Private Limited, the primary company behind Jasco Labs, for FY 2024. Revenue was ₹5.90 Cr (+3% year on year). Net profit was ₹16.9 Lakh (3% margin). EBITDA was ₹27.4 Lakh (5% margin). Revenue has grown at a compounded annual rate of +8% over three years and +3% over five years.
- ₹5.90 CrRevenue · FY 2024 · +3% YoY
- ₹16.9 LakhNet profit · 3% margin
- ₹27.4 LakhEBITDA · 5% margin
- ₹3 LakhPaid-up capital
- +8%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jasco Labs Private Limited are on its company page.
Detailed financial statements for Jasco Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Jasco Labs
Jasco Labs has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Jasco Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Jasco Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jasco Labs
Jasco Labs was founded in 2005.
Jasco Labs is headquartered in Chandigarh, India.
The primary company behind Jasco Labs, Jasco Labs Private Limited, reported revenue of ₹5.90 Cr for FY 2024, up 3% year on year.
Jasco Labs, established in 2005, is a manufacturer and trader of pharmaceutical products including antibiotics, calcium preparations, anti-allergic, and psychiatric medicines. They operate through advanced facilities in India and New Zealand, offering contract manufacturing and third-party services. The company focuses on high-quality production with WHO-GMP standards, supplying formulations like tablets and injections to various clients in the pharmaceutical industry. Their activities include trading and marketing support to ensure effective distribution.
Jasco Labs's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Jasco Labs offers Capsules, Tablets, Injections, Cream, and Syrup.
Jasco Labs operates through Jasco Labs Private Limited.
The legal entities of Jasco Labs currently have 3 directors, including Ravdeep Singh Matta, Jasmeet Singh, Raminder Singh Matta.